Dose | 0 mGy∙day−1 | 3 mGy∙day−1 | p | ||
Subgroups of dogs® | WO0 | W0 | WO3: WO0 | W3: W0 | |
Average life span, years | 10.7 | 11.8 | 1.10 | 0.97 | p ≤ 0.05 |
Body Weight loss, % | 15 | 21 | 2.13 | 0.90 | p ≤ 0.05 |
Cancer (autopsy), % | 39.5 | 60** | 1.14 | 0.97 |
|
Hematoblastoses, % | 9.4 | 6.8 | 0 | 1.0 | p ≤ 0.05 |
Anemia, % | 2.1 | 6.8 | 0 | 0 |
|
Inflammation, % | 57 | 75*** | 0.46 | 0.47 |
|
Diarrhea, % | 52 | 51 | 1.48 | 1.49 |
|
Vomiting, % | 50 | 41 | 1.88 | 2.27 |
|
Metaplasia, % | 1 | 0 | 19 | >17 |
|
Atrophy, % | 9.3 | 19*** | 6.6 | 2.68 | p ≤ 0.001 |
−k1 year−1 | 1.22 | 1.22 | 0.65 | 0.72 | p ≤ 0.001 |
−k2 year−1 | 0.078 | 0.028*** | 0.33 | 0.45 | p ≤ 0.001 |
Reduced appetite, % | 19 | 23 | 1.21 | 1.83 | p ≤ 0.001 |
Dogs, which are with (W) tumors benign or unknown nature (clinically), or without them (WO) during 10 years of life. | 0 | 100*** | 0 | 100*** | p ≤ 0.001 |